PCM
CNCR

Prelude Capital Management’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History

Prelude Capital Management’s Portfolio CNCR Stock Details CNCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-12,050
Closed -$291K – 1386
2018
Q2 		$291K Buy
+12,050
New +$291K 0.02% 528